Tracky is a private, local-first health tracker for GLP-1 medication users to log injections, weight trends, and nutritional intake via AI photo analysis.
The App DNA
What makes this app unique?
The app removes the privacy friction of cloud-based health platforms, serving users who require a secure, dedicated space for sensitive medication and weight-loss data.
For Individuals using GLP-1 medications for weight loss or type 2 diabetes management who require simple, privacy-focused tracking tools.
What does it look like?
Key features
Identifies meal contents from photos to calculate nutritional data.
Logs weekly injection schedules and medication history.
Stores all health data and photos on the device.
How much does it cost?
Tracky is currently free with no visible subscription or IAP gates, serving as a pure utility tool.
Velocity
Maintenance developmentperformanceopaqueShow more...
Tracky: GLP-1 Tracker maintains a maintenance-level cadence, shipping 2 releases over the observed window. Development is currently focused on minor stability and performance improvements rather than new feature sets. The publisher utilizes opaque release notes, providing no visibility into specific functional changes or roadmap progress. The current release frequency suggests a focus on basic upkeep rather than active feature expansion.
Who built it?
DOFA TECH YAZILIM HIZMETLERI ANONIM SIRKETI
4 apps tracked · Health & Fitness
FaceAI: AI Photo Video Editor
TaleAI: Bedtime Stories
ThisBooth: retro photo stripsUser Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Tracky: GLP-1 Tracker
How's the Health & Fitness market?
Tracky maintains a high 4.8-star rating across 227 reviews, signaling strong product-market fit for its privacy-focused niche. However, the lack of major updates in the last six months suggests a maintenance posture that limits its ability to capture broader market share from established health platforms.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Tracky: GLP-1 Tracker
Where is it heading?
The GLP-1 tracking market is consolidating as users seek specialized tools for their specific medication journeys. Tracky is currently advantaged by its privacy-first design, but its maintenance-only cadence limits its ability to defend this position against larger health platforms that may soon offer similar, more integrated solutions.
- High user satisfaction (4.8 stars) confirms the privacy-first value proposition resonates with the target audience.
- The maintenance-only release cadence indicates a lack of active feature expansion, which leaves the app vulnerable to feature-parity moves by larger competitors.
The SWOT
- Local-only data storage removes privacy-related friction for sensitive medical tracking
- Integrating automated medication-refill reminders could increase long-term retention for chronic GLP-1 users
Next best moves
Ship medication-refill reminders because users require consistency for GLP-1 therapy → increase long-term retention
The counter-intuitive read
The app's lack of cloud sync is a feature, not a bug…
Read the full takeSince the last report: The product roadmap shifted from prioritizing AI calorie counter accuracy to implementing medication-refill reminders to improve long-term retention for chronic users. This pivot marks a transition from a purely passive tracking utility toward a more proactive engagement model.
Bottom line
Tracky's privacy-first architecture provides a defensible niche, but the lack of active feature development risks stagnation against larger health platforms. Prioritizing retention-focused features like medication-refill reminders would solidify its value for chronic users before competitors enter the space.
Unlock 1 critical friction, 1 market threat and the analyst’s take.
Access the full report for freeSources
- [1] App Store, source
Report last updated